23,187 Shares in Envista Holdings Co. (NYSE:NVST) Bought by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC bought a new stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 23,187 shares of the company's stock, valued at approximately $447,000.

Several other institutional investors also recently bought and sold shares of NVST. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Envista during the 4th quarter worth about $53,000. Lecap Asset Management Ltd. acquired a new stake in Envista during the fourth quarter worth about $281,000. Hotchkis & Wiley Capital Management LLC purchased a new position in Envista during the third quarter valued at approximately $14,965,000. Geode Capital Management LLC lifted its holdings in Envista by 2.5% in the third quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company's stock valued at $57,233,000 after acquiring an additional 71,435 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Envista in the 3rd quarter worth approximately $521,000.

Envista Stock Down 3.9 %

Shares of NVST traded down $0.63 during trading hours on Friday, hitting $15.47. 5,800,011 shares of the company were exchanged, compared to its average volume of 2,452,247. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The company has a market cap of $2.66 billion, a PE ratio of -2.38, a PEG ratio of 1.27 and a beta of 1.12. The firm's 50 day moving average is $19.18 and its 200-day moving average is $19.53. Envista Holdings Co. has a 52 week low of $14.77 and a 52 week high of $23.00.

Remove Ads

Envista (NYSE:NVST - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, equities research analysts forecast that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on NVST. Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a report on Thursday, March 6th. JPMorgan Chase & Co. reduced their price target on Envista from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Thursday, March 6th. New Street Research set a $19.00 price objective on Envista in a report on Thursday, March 6th. Jefferies Financial Group upped their target price on Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Finally, UBS Group dropped their price target on shares of Envista from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Monday, March 10th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Envista presently has an average rating of "Hold" and an average target price of $20.18.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.